Functional herbs are orally administered as decoctions; therefore, the constituents inevitably contact with intestinal microflora in the alimentary tract. Some hydrophilic constituents, mainly glycosides, may be transformed by intestinal bacteria during their absorption through the gastrointestinal tract. Studies on the metabolism of such constituents by intestinal microflora are very important in understanding their biological effects [5, 10, 11] . D-Xylose is a common component of several polysaccharides and glycosides, such as xylan, ginsenosides, and isoflavone glycosides [12, 14, 21] . Ginsenoside Ra1, isolated from Ginseng (the root of Panax ginseng C.A. Mayer, Araliaceae), and kakkalide, the major constituent of arrowroot flos (the flower of Puerariae thunbergiana, family Leguminosae), are typical D-xylose-bound glycosides [17, 21] .
Ginseng is frequently used against tumors, stress, and diabetes in functional foods and traditional medicines [18] . Arrowroot is a commonly used herb in traditional Chinese medicine for counteracting symptoms associated with drinking alcohol, liver injury, and the menopause [9, 13, 14, 16, 19] . To express the pharmacological actions of these herbs, their constituents are thought to be metabolized in the intestines by intestinal bacteria following their oral administration [2, [6] [7] [8] 13] . To identify their biological forms, therefore, their metabolites must be isolated and their pharmacological effects need to be investigated. In relation to their metabolites, Shin et al. [17] isolated the ginsenoside Ra-metabolizing intestinal bacterium, Bifidobacterium breve K-110, from human feces and also *Corresponding author Phone: +82-2-961-0374; Fax: +82-2-957-5030; E-mail: dhkim@khu.ac.kr purified β-D-xylosidase (E.C. 3.2.1.37). This enzyme has been found to hydrolyze ginsenosides Ra1/Ra2 and kakkalide to ginsenosides Rb2/Rc and kakkalidone, respectively (Fig. 1) .
In the present study, the gene encoding the β-Dxylosidase of B. breve K-110 was sequenced and cloned. The cloned recombinant enzyme, designated XylBK-100, was expressed in Escherichia coli, with its substrate specificities and enzymatic properties also investigated.
MATRERIALS AND METHODS
Bacterial Strains and Culture Conditions B. breve K-110 was cultured at 37 o C in GAM broth (Nissui Pharmaceutical Co., Japan). This strain was isolated from human fresh feces, and identified as B. breve by analyses of its biochemical properties [15] and 16S rRNA homology (95% identity of B. breve KB69). E. coli strains BL21(DE3) and JM109(DE3) were employed for gene cloning and expression, respectively, with the strains grown in Luria-Bertani (LB) broth.
Cloning and Sequence Analysis of β-D-Xylosidase-Encoding
Gene β-D-Xylosidase of B. breve K-110 was amplified by PCR using BkXyl_F1 (5'-CGC GGATCC TAT GAC CAC CTG GAT TGC A-3') and BkXyl_R (5'-CGC CTCGAG GTC CAG CAC GAA GGT GTT C-3') as the primer pair, which were picked from the GenBank database (GenBank Accession No. DQ327717 and AP009256). The primers were designed to contain restriction enzyme sites (BamHI and XhoI) for cloning into the Ex vector. The Taq polymerase system (TaKaRa, Japan) conditions were as follows: 1 cycle at 94 Protein Expression and Purification of XylBK-110 pET26b(+)_BKXyl was constructed using the pET26b(+) vector and the β-D-xylosidase-encoding full-length gene, cut from T_BKXyl. This was transformed into an expression host, E. coli BL21(DE3). The transformed expression host cells were grown at 37 o C, with shaking at 250 rpm, in 800 ml of LB broth containing 30 µg/ml of kanamycin, until OD of 0.6 at 600 nm, with 1 mM isopropyl-β-Dthiogalactopyranoside (IPTG) added to induce the T7/lac promoter, and then incubated overnight at 20 o C, with shaking. The harvested cells were resuspended in bind/wash buffer (20 mM sodium phosphate buffer containing 0.5 M NaCl and 20 mM imidazole, pH 7.4), sonicated 5 times for 2 min (Ultrasonic Processor QE501, Eyela Co., Japan), and then centrifuged. All these steps were performed at 4 o C. The supernatant was loaded onto a 5 ml IMAC HP column (GE Healthcare, France) charged with Ni 2+ ions. The recombinant β-D-xylosidase, designated XylBK-110, was eluted using a buffer (20 mM sodium phosphate buffer containing 0.5 M NaCl and 500 mM imidazole, pH 7.4). Purified XylBK-110 was desalted and concentrated using a Vivaspin concentrator (Satorius, Germany).
Protein Determination and Electrophoresis
The protein concentration was measured according to the Bradford method [4] , with bovine serum albumin as the standard. Electrophoresis was performed using a discontinuous polyacrylamide gel (10% separating gel, 5% stacking gel, 1 mm thickness), with Coomassie brilliant blue R250, under denatured conditions employing the procedure described by Laemmli. The molecular weights of the purified enzymes were estimated by comparison with molecular weight markers (Fermentas, USA).
Enzyme Assay of XylBK-110 A reaction mixture containing 0.2 ml of 2 mM pNPX (or other substrates), 0.1 ml of the enzymes, and 0.3 ml of sodium phosphate buffer (pH 7.0) was incubated for 30 min. The hydrolytic reactions were stopped by the addition of 0.5 M NaOH, and the absorbance was measured at 405 nm.
The enzyme activity was determined using a standard calibration curve for p-nitrophenol (pNP). One unit of enzyme activity was defined as the amount of enzyme required to catalyze the formation of 1.0 µmol of pNP per minute under the standard assay conditions, with the specific activity as units per milligram protein.
To assay the hydrolytic activity of XylBK-110 toward ginsenoside Ra1 and kakkalide, these constituents, instead of pNPX, were added to the above reaction mixture (1 ml) containing XylBK-110 (0.004 unit), with the reactions stopped by extraction with EtOAc and BuOH, respectively. The EtOAc fraction was evaporated, and then analyzed using thin-layer chromatography (TLC) and an HPLC system. The TLC plate [TLC plate, silica gel 60F 254 (Merck Co., USA); and developing solvent, CHCl 3 -MeOH-H 2 O = 65:35:10] was stained by spraying with 95:5 MeOH:H 2 SO 4 , followed by heating. All plates were then analyzed using the image analyzing program, ImageQuant (GE Healthcare, U.S.A.). The HPLC system consisted of a Younglin SP930D quaternary pump, a manual injector (Model 7125, Rheodyne, CA, USA), equipped with a 20 µl sample loop, and a Younglin UV730D detector. The instrument was controlled and the data processed using a Yonglin AutoChro-3000 (1.0.0 build No.5). The analytical column was a Develosil C30-UG-5 (250 × 4.6 mm i.d., 5 µm, 100 o C; Nomura Chemical, Japan), protected by C18 Security Guard Cartridges (Phenomenex, Torrance, CA, USA). Solvents A and B were water and acetonitrile, respectively. Separations were performed on 15 µl sample injection volumes, with a linear gradient of 0-100% solvent B over a period of 25 min, at a flow rate of 1.0 ml/min, with detection at 254 nm.
The optimal pH for the purified enzyme (0.002 unit) was examined using the following buffers: 50 mM sodium acetate buffer (pH 4.0-5.5), 50 mM sodium phosphate buffer (pH 6.0-8.0), and 50 mM NaOH-glycine buffer (pH 8.0-10.0).
For determination of the optimal temperature, 50 mM phosphate buffer containing the enzyme (0.002 unit) was pre-incubated at each temperature (30-60 o C) for 3 min, with the standard assay then performed at each temperature.
Enzyme Kinetics
The kinetic parameters (K m and V max ) of pNPX, kakkalide, and ginsenoside Ra1 were determined using variable substrate concentrations 
RESULTS

Sequence Analysis
A full-length gene encoding the β-D-xylosidase of B. breve K-110 was 1,347 bp in length and encoded a 448-aminoacid protein. The present β-D-xylosidase was one of the glycosyl hydrolase family 30 (GH30), which revealed 82% and 98%, and 93% and 99% identities with B. adolscentis ATCC 15703' glycosyl hydrolase and B. adolscentis Int57's β-D-xylosidase at the DNA and protein levels, respectively (Fig. 2) .
Protein Purification DNA sequencing of the construct, pET29b-Bkxyl, revealed that the expected sequence was correctly inserted in-frame with the C-terminal His tag of the vector. XylBK-110 was well expressed in the E. coli expression host, and easily purified to apparent homogeneity using HiTrap-IMAC affinity chromatography. A single band was observed in the SDS-PAGE of the purified enzyme (Fig. 3) . The molecular mass of the purified recombinant enzyme was 55.7 kDa. XylBK-110 was purified 109.9-fold from the crude extract, with a yield of 84%, using a single-step purification (Table 1) .
Effects of pH and Temperature
The optimal reaction conditions for XylBK-110 were determined using a series of experiments. The cloned enzyme exhibited activities from over pH 4.5 to 9.5, with the effect of pH on the activity of XylBK-110 described by a bell-shaped curve having an optimum at 6.0 (data not shown). Moreover, the enzyme activity was stable within the temperature range 40 to 50 o C, but was rapidly lost above 50 o C, with the optimal temperature being 45 o C (data not shown).
Substrate Specificity and Enzyme Kinetics
The substrate specificity of XylBK-110 was examined using various synthetic substrates and natural glycosides. The recombinant enzyme, XylBK-110, potently hydrolyzed kakkalide to kakkalidone, but did not produce irisolidone (Fig. 4) . XylBK-110 hydrolyzed the external β-xylosyl group conjugated in glycosides, such as kakkalide and ginsenoside Ra1, but did not hydrolyze the external β-glucose group, such as kakkalidone and ginsenoside Rb2. The best substrate of the XylBK-110 was kakkalide, followed by pNPX and ginsenoside Ra1. XlyBK-110 efficiently hydrolyzed pNPX, but did not act on the other Using pNPX, kakkalide, and ginsenoside Ra1 as substrates for the purified enzyme, the K m and V max were estimated to be 1.45 mM and 10.75 mmol/min/mg for pNPX, 0.05 mM and 9.3 mmol/min/mg for kakkalide, and 0.4 mM and 0.17 mmol.min/mg for ginsenoside Ra1, respectively ( Table 2) .
DISCUSSION
β-Xylosidases are useful for chemical and biological studies of xylose-bound natural products such as kakkalide and ginsenoside Ra. The biological activities of these glycosides are thought to originate from their hydrolyzed products. Therefore, it is important to obtain the hydrolyzing enzyme(s) to investigate their biological effects. Existing xylanases, previously cloned and expressed from many microbes, mainly catalyze the hydrolysis of nonreducing terminal β-D-xylopyranoside linkages in arabinofuranosecontaining polysaccharides, such as xylan. Recently, Shin et al. [17] reported on the purified ginsenoside Ra1 and kakkalide-hydrolyzing β-D-xylosidase from B. breve K-110, a human intestinal bacterium. The β-D-xylosidase from B. breve K-110 is a single-subunit, exo-type enzyme, with enzymatic properties distinct from other xylanases, such as thermostability and substrate specificity. However, the novel enzyme was not cloned or expressed.
Therefore, attempts were made to sequence the fulllength gene encoding the β-D-xylosidases from B. breve K-110 for cloning and expression of its β-D-xylosidase, which can easily hydrolyze xylose-bound natural products, such as kakkalide and ginsenoside Ra. The cloned β-Dxylosidase was 1,347 bp and encoded 448 amino acids. β-Xylosidases have been reported to be produced by many microbes. These β-xylosidases are currently classified into families 3, 30, 39, 43, 52, 54, and 116 of the glycosyl hydrolases (GHs), based on their amino acid sequence similarities. Of these, the cloned β-D-xylosidase from B. breve K-110 belongs to the O-glycosyl hydrolase family 30 and showed high homologies with B. adolescentis Int 57's β-D-xylosidase and B. adolescentis ATCC 15703's glycosyl hydrolase at both the DNA and protein levels (98% and 82%, and 99% and 93%). However, no significant homologies with other xylanases previously cloned and expressed were observed. The molecular mass of the purified XylBK-110, containing the partial vector sequences, was found to be 55.7 kDa, using SDS-PAGE and a protein molecular weight calculator, protein calculator v 3.3. The optimal pH and temperature of the enzymes were 6.0 and 45 o C, respectively. When the substrate specificity was investigated, XylBK-110 greatly hydrolyzed kakkalide, followed by pNPX and ginsenoside Ra. These results suggested that XylBK-110 may prefer xylose linked with a sugar compound rather than xylose linked with an aglycone. Moreover, the xylanases from other species can hydrolyze various p-nitrophenyl-β-D-glycosides, such as p-nitrophenyl-β-D-glucopyranoside, p-nitrophenyl-β-Dfucopyranoside, and p-nitrophenyl-α-L-arabinofuranoside. However, XylBK-110 selectively hydrolyzed pNPX. The substrate specificity and characterization of β-D-xylosidase were different from the previously reported β-D-xylosidases.
In conclusion, this is the first report on the cloning and expression of a β-D-xylosidase, hydrolyzing kakkalide and ginsenoside Ra, from human intestinal microflora. 
